Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma, Expert Opinion on Investigational Drugs, April 2013, Informa Healthcare,
DOI: 10.1517/13543784.2013.788643.
You can read the full text:
Contributors
The following have contributed to this page
